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A full compilation of Salvador De Aza works on biomedical materials is a huge task beyond the aim of this paper; instead 
it is intended to stand out De Aza’s thoughts and leadership in the field of Bioceramics and to pay tribute to his memory. 
The most outstanding works of Professor Salvador De Aza related to Bioceramics, from the point of view of the authors, are 
commented and discussed.
Topics the authors chose among many other De Aza’s works on biomedical materials are: The prediction and demonstration 
of bioactivity in pseudo-wollastonite ceramics; the use of phase diagrams to design bulk-bioactive ceramics with eutectic 
microstructures; the relationship between bioactivity and microstructure in ceramic biomaterials; and the studies on the 
polymorphic phase transitions in tricalcium phosphate.
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Las principales contribuciones de Salvador de Aza a las Biocerámicas
Una recopilación completa de la obra de Salvador De Aza sobre materiales biomédicos es una tarea enorme más allá del 
objetivo de este trabajo, que está destinado a destacar sus enfoques y liderazgo en el campo de las Biocerámicas y rendir 
merecido tributo a su memoria. Para ello se discuten y comentan aquellos trabajos del Profesor Salvador De Aza sobre 
Biocerámicas que a juicio de los autores resultan más sobresalientes. Entre muchos otros trabajos de De Aza sobre materiales 
biomédicos, los autores han elegido los siguientes tópicos: la predicción y demostración de la bioactividad de las cerámicas 
de pseudo-wollastonita; el uso de diagramas de fase para el diseño de materiales bioactivos en masa con microestructura 
eutéctica; y sus estudios sobre la transición polimorfica de fases en el fosfato tricálcico. 
Palabras Clave: Biocerámicas, Bioeutectic, Wollastonita, Pseudowollastonita, Fosfato tricálcico, Microestructura, Transformación polimórfica
1. IntroductIon
Half a year has passed since the sudden and unexpected 
decease of Professor Salvador De Aza, time enough to digest 
pain and sadness and to recover the serenity needed to recall 
his thoughts and works related to the field of Bioceramics and 
attempt to review and resume it.
Salvador De Aza is well known among ceramists from 
Europe, North America and even Asia for his scientific and 
technical works on theoretical and experimental studies of 
phase equilibrium diagrams and their application to the 
development of materials exhibiting specific properties, and 
the application of the scientific methods to ceramic industry. 
In fact, it has been recognised that the S. De Aza decisively 
contributed to the blooming that Spanish ceramic industry 
experienced since the 1970s till the first years of the present 
century (1).
However, themes related to conventional ceramics do 
not predominate evidently when S. De Aza’s scientific 
production is analysed. Forty three per cent of his papers 
referenced by the Web of Knowledge deals on Biomaterials 
and the percentage increases to 53 when the last 20 years are 
considered. Moreover, the most popular of his papers (more 
than a hundred citations) reports the in vitro evaluation of the 
bioactivity of pseudowollastonite bioceramic (2), and more 
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than a half of those with 20 or more citations are related to 
Bioceramics too, which indicates the professional interest he 
devoted to the subject.
The first encounter of Prof. De Aza with biomedical 
materials happened during the Course on “Biomaterials and 
Biocompatibility: Materials, Techniques and Applications” 
held at Pazo de Mariñan, A Coruña, Galicia, in June 1990. The 
course was organised by De Aza’s closest friend J. Espinosa 
with the support of CSIC and the UE-Comett I Programme. 
Spanish scientists from Materials Science, Medicine and 
Dentistry fields were gathered up for almost a week and 
attended a series of lectures on hot topics on Biomaterials and 
Biocompatibility. After the lectures, discussion was promoted 
between Materials Science and Medicine scientists. From these 
discussions and exchange several collaboration actions arose, 
some of them lasting till present day. Most of attendants to 
that course agree in considering it a milestone in research 
and development of biomedical materials in Spain (3). Soon 
afterward Salvador De Aza started his works on wollastonite 
bioceramics and its eutectic composition with tricalcium 
phosphate jointly with her daughter P. N. De Aza and F. 
Guitian from the Instituto de Cerámica de Galicia, University 
of Santiago de Compostela. Besides, he brought the staff of his 
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team of Phase Equilibrium Diagrams and Refractories at the 
Instituto de Cerámica y Vidrio, CSIC, in Bioceramics research. 
All of his works on the subject are characterized by the good 
use of his sound knowledge on physical chemistry of silicates 
to design materials with the desired structure and properties.
An attempt to summarize Prof. De Aza’s main contributions 
related to Bioceramics is provided below.
2. PSeudowoLLAStonIte: the fIrSt PoLycryStAL-
LIne cerAmIc rePorted AS BIoActIve
At the beginning of 1990 glasses and glass-ceramics mainly 
constituted of CaO, P
2
O
5
 and SiO
2
 were the only known 
materials exhibiting in vitro type A bioactivity (4-7). In 1991 
Ohura et al. showed that a P
2
O
5
-free CaO-SiO
2
 glass was 
also able to develop an apatite (Ap) layer on its surface after 
soaking in simulated body fluid (SBF) (8).
Fig. 1. (a) The psW unit cell showing the layering feature of Ca atoms 
and Si
3
O
9
 ternary rings along the c axis. (b) Projection along c-axis of 
the unit cell of psW displaying Ca atoms stacking in columns parallel 
to c-axis.
Fig. 2. Schematic representation of the mechanism for Ap formation on 
polycrystalline pseudowollastonite bodies (Redrawn from (12)).
S. De Aza et al. were the first to demonstrate that 
polycrystalline silicate-based ceramics may also be bioactive. 
The silicate chosen was pseudowollastonite (psW; psCaSiO
3
), 
a polymorph of CaSiO
3
 stable above 1030 ºC to the melting 
point, which may exist in metastable state at room temperature. 
The selection of psW was not arbitrary. S. De Aza used to 
point out that empiricism was the main shortcoming in the 
works of Hench (4) and Kokubo (5) conducting to Bioglass® 
and Cerabone A/W® glass-ceramic, respectively. In contrast, 
De Aza et al. chose psW because of its crystalline structure, 
keeping in mind that type A bioactive materials bond directly 
to bone through a surface apatite (Ap) layer formed by a 
complex process which starts with the exchange of H
3
O+ ions 
from the environment for labile Na+, K+, Ca2+, Mg2+, etc., ions 
existing in the glass or glass ceramic matrix. The monoclinic 
(C2/c) unit cell of psW is constituted of four layers, each of 
which is composed of alternate layers of Si
3
O
9
 tetrahedral 
rings and Ca atoms, parallel to ab-plane (see Fig. 1a). Besides, 
Ca atoms are disposed in columns oriented along c-axis and 
contained in the channels left between SiO
4
 tetrahedra (Fig 
1b) (9).
The rational was that such structure should permit a 
fast diffusion of H
3
O+ ions from physiological fluid inside 
the crystal and its exchange with Ca ions as required for 
starting the Ap layer formation on the surface of bioactive 
materials. The idea was supported by existing reports on the 
dissolution of natural wollastonite-2M (W-2M, CaSiO
3
-2M), 
which proceeds in a similar way (10, 11).
In 1994 appeared the first report by De Aza et al. on the 
in vitro bioactivity exhibited by psW (2,12). They observed 
the formation of a surface Ap layer of psW polycrystalline 
ceramic when soaked in a solution of SBF. They stated that 
at the beginning of the reaction of psW with physiological 
fluid an ionic exchange of Ca2+ for 2H+ takes place in the psW 
network, which is supported by the results of Weissbart and 
Rimstidt, and Bailey and Ressman (10, 11) (Fig. 2a). This step 
is controlled by diffusion of the ionic species through the 
solution film in contact with the surface of the ceramic: the 
release of Ca2+ decreases as interfacial pH increases. As a result 
of the above ionic exchange the crystalline psW network in 
the surface layer transforms into an amorphous silica phase 
and the Ca2+ and OH- concentrations in the solution increase 
(Fig. 2b). These conditions induce partial dissolution of 
amorphous silica (probably as H
4
SiO
4
 and H
3
SiO
4
- species 
(14)) and subsequent precipitation of Ap (Fig. 2c). Reaction 
goes on until the formed Ap layer hinders the ionic exchange 
(2, 12, 13).
Subsequent works showed that psW manifests in vitro 
bioactivity also in human saliva (15) and it was soon confirmed 
that it is also a type A bioactive material in vivo. Implantation 
studies conducted in rat tibiae showed that new bone was 
growing in direct contact with the implants. Osteoblastic cells 
migrated towards the implant-tissue interface and colonized 
the surface at the contact areas with the cortical and bone 
marrow. The new bone formed was fully mineralized and 
after 12 weeks the bone-implant interface active remained 
biologically and chemically active (16).
S. De Aza always recognized the relevance of the early 
works of E. M. Carlisle (17-19) on the role of silicon in bone 
metabolism and mineralization, which laid the foundations 
for the more recent findings on ostegenesis and angiogenesis 
produced by the dissolution products of Bioglass® (20, 21). 
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De Aza et al. supposed that the dissolution products of psW 
act in a similar way and they performed a series of studies 
employing acellular and cellular in vitro models to proof 
their thesis. They found that neither significant alteration of 
membrane integrity nor signs of cell suffering were detected 
when human osteosarcoma cells were cultured in presence of 
extracts of psW in culture medium. However, increased cell 
metabolism did was observed for cultures made with extracts 
corresponding to the longest extraction time (22).
Furthermore, when rat calvarial osteoblasts were cultured 
in the presence of psW ceramic they adhered rapidly to the psW 
surface and this process seemed to be aided by the binding of 
serum proteins to the surface Ap layer. Additionally, a novel 
phenomenon was observed whereby osteoblasts far away 
from the material changed its phenotype, which reinforced the 
suggestion that the release of soluble factors as well as direct 
interaction of osteoblasts with the surface of the material may 
mediate the osteogenic effects of bioactive psW ceramic (23).
De Aza et al. developed effective solid state synthetic and 
analytical methods to prepare and characterize psW ceramic 
(24) and the products of its surface reaction with SBF (25-27). 
They also evaluated the feasibility to employ natural W-2M as 
a cheaper precursor for obtaining psW ceramics (28, 29).
3. BIoeutectIc®: the fIrSt BuLk-BIoActIve mAterIAL
Bioactive ceramics, bioglasses, and glass-ceramics have 
succeeded for several decades for bone repairing applications. 
They are capable to bond tightly to bone; however they are 
not fully replaced by new bone. The dissolution-precipitation 
processes responsible for the formation of the Ap layer 
proceed only in a relatively thin surface layer, the bulk of 
the material remaining unchanged. The golden standard for 
bone repairing is a material such as it gradually reabsorbs at 
the same rate that new bone grows, so that it is completely 
replaced by new bone after an appropriate period of time.
Macroporous scaffolds are recommended to achieve 
complete colonization and integration of the implant to 
bone, however, the low strength of macroporous materials 
during the initial implantation period, when the new formed 
tissue has not colonized the porous implant yet, limits their 
applications to low stress bearing situations (30).
De Aza et al. proposed a new approach to overcome 
this problem which consists in a dense and strong bioactive 
ceramic capable to degrade and to develop a porous structure 
in situ after implantation. Such a material should be composed 
of at least two phases, one bioactive and the other resorbable 
(30-34). S. De Aza knew very well the thermodynamic and 
kinetic rules of binary systems with and eutectic invariant 
point. In a binary system a solid crystalline microstructure 
consisting of discrete and distinguishable domains of both 
phases is obtained when solidifies a melt with the eutectic 
composition (35). The connectivity of the resulting structure is 
generally 1-3 or 2-2 (36), being the last the most common (35).
After reviewing several systems and on thermodynamic 
basis, they selected the binary system wollastonite-tricalcium 
phosphate (CaSiO
3
-Ca
3
(PO
4
)
2
) where an invariant eutectic 
point exists. This way a eutectic microstructure consisting of 
psW and α-Ca
3
(PO
4
)
2
 (α-tricalcium phosphate; α-TCP) may 
be obtained that fulfills the requirement mentioned above: to 
be composed of a resorbable phase (α-TCP) and a bioactive 
one (psW). De Aza et al. studied the system and found the 
exact eutectic composition and temperature are CaSiO
3
 60 
wt.-%, Ca
3
(PO
4
)
2
 40 wt.-%, and 1402 ± 3 ºC, respectively (37). 
Then they prepared a ceramic material with a microstructure 
formed by rounded colonies (rosettes) by slow solidification of 
a melt with the eutectic composition, under a radial gradient 
of heat extraction (31-34, 38).
Figure 3 shows a Scanning Electron Microscopy (SEM) 
photograph of the microstructure of the eutectic material 
comprising quasi-spherical colonies formed by alternating 
lamellae of psW and α-TCP. The colonies or rosettes are 
always embedded in psW because of the greater volume 
fraction of this phase. The new material was called Bioeutectic 
and the mark was registered at the Oficina Española de 
Patentes y Marcas under file M 1780697.
De Aza et al. observed fast increase of the concentration 
dissolved Si when Bioutectic® was soaked in SBF corresponding 
to dissolution of psW lamellae. On the other hand Ca and P 
concentrations slowly increased and decreased, respectively. 
At the same time they observed the formation of a typical 
Ap layer on the surface of the material (Fig. 4). The study 
Fig. 3. SEM micrograph of Bioeutectic® after etching in diluted acetic 
acid. (a) General view; (b) Detailed view of a colony. Dark areas cor-
respond to empty spaces left by α-TCP which dissolves during acid 
etching (from S. De Aza personal files).
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of polished cross sections of Bioutectic® after 1 week in SBF 
by SEM and Energy Dispersive X-Ray Spectroscopy (EDS) 
confirmed that psW dissolves rapidly and remains a porous 
calcium phosphate phase as shown in Fig. 5. (31-34). To 
identify the nature of the remaining calcium phosphate phase 
they made good use of their studies on Raman spectra of 
calcium phosphates (25-27) and found that poorly crystallized 
Ap was the remaining phase after Bioeutectic® reacted with 
SBF for 1 week.
Thus, the experimental findings contradicted the 
hypothesis they employed during the initial design of the 
material, i. e. psW was the resorbable phase instead of 
α-TCP, which in turn was the one that transformed into Ap. 
They explained the experimental facts with the mechanism 
schematized in Fig. 6. Ion exchange of Ca2+ for H
3
O+ takes 
place at the psW lamellae with the consequent formation of a 
layer of amorphous silica and increase in pH at the interface 
SBF-Bioeutectic®. As a result of the increase in pH amorphous 
silica dissolves leaving channels where fresh SBF penetrates to 
continue the process of dissolution of psW. As psW dissolves 
the channels left between α-TCP lamellae become deeper and 
pH increase because of diffusion is restrained. 
These conditions favor the pseudomorphic transformation 
of α-TCP to Ap according to the reaction of Eq. 1.
 
       Eq. 1
At the same time Ap layer is formed on the surface of 
Bioeutectic® as result of the reaction of Eq. 2.
 
       Eq. 2
As the surface Ap layer becomes thicker the inner reaction 
is slowed down until it finally stops (31-34).
Bioeutectic® reacted in a similar way when SBF was 
substituted by human parotid saliva but in lesser extension 
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Fig. 4. SEM images of the surface of Bioeutectic® after immersion in 
SBF for (a) 1 week; and (b) 2 week (Reproduced from (40).
Fig. 5. SEM micrograph of a cross section of Bioeutectic® material after 
soaking in SBF for 1 week and the corresponding Si, P. and Ca X-ray 
maps (from S. De Aza personal files).
Fig. 6. Schematic representation of the mechanism of Ap formation 
in Bioeutectic during immersion in SBF. n=0, 1 (Redrawn from (31)).
α
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and the resulting Ap phase presented partial substitution of 
CO
3
2- for PO
4
3- as evidenced the µ-Raman spectra (39).
On the other hand, De Aza et al. realized that the in 
vitro bioactivity test based in soaking the material in static 
fluids does not reproduce the actual in vivo conditions, 
where physiological fluids circulate continuously and its 
composition is kept invariable through homeostasis. They 
designed a dynamic test consisting in immersing the material 
in a slow stream of SFB (50 cm3/h) instead of using a static 
solution. In these conditions ions dissolved from the psW 
surface can easily leave the sample surface and diffuse into 
the SBF solution. The concentration of ionic Ca at the sample 
surface concentration is approximately the same than in 
the bulk of SBF and supersaturation is not reached, thus 
preventing nucleation and precipitation of Ap on the outer 
surface of the material through the reaction of the Eq. 2. 
However, high concentrations of Ca2+ and OH- can be reached 
in the channels formed after dissolution of psW, and α-TCP 
reacts pseudomophically into Ap according to the reaction of 
Eq. 1 rendering an apatitic porous structure similar to that of 
cancellous bone as shown in Fig. 7 (40).
The above results supported the statement S. De Aza use 
to issue: “Bioeutectic® is the only bioactive material, at present, 
which is totally colonized in SBF”.
MAIN CONTRIBUTIONS TO BIOCERAMICS By SALVADOR DE AzA
Fig. 7. SEM images of the surface of Bioutectic® after immersion in dy-
namic SBF (50 cm3/h) for 2 weeks. (a) Surface; and (b) fracture surface 
(Reproduced from (40).
Fig. 8. SEM micrographs of cross sections of materials showing the 
Ap layer formed after soaking in SBF for 1 week. (a) Bioeutectic®; (b) 
Eutectic glass (Reproduced from (45)).
4. mIcroStructure determIneS BIoActIvIty
As a good ceramist, S. De Aza knew that the properties 
and performance of ceramics depend on neither their 
intrinsic properties nor its chemical composition, but the 
microstructure which in turn is determined by the processing 
method employed during manufacturing. Keeping in mind 
that in vitro bioactivity is a property that determines the 
performance of a material in a given environment he realized 
the importance of studying its dependence on microstructure. 
The first case he studied was the above mentioned eutectic 
composition of the system CaSiO
3
-Ca
3
(PO
4
)
2
. (37). De Aza et al. 
prepared two materials from the eutectic composition (CaSiO
3
 
60 wt.-% - Ca
3
(PO
4
)
2
 40 wt.-%). The first one was Bioeutectic®, 
a polycrystalline biphasic ceramic with the typical irregular 
eutectic microstructure shown in Fig. 3. It was obtained as 
described elsewhere by slow heat extraction from the melt 
under a radial heat gradient (32-35, 41, 42). The second one, 
with the same eutectic composition was a glass, obtained by 
quenching the melt to room temperature and annealing at 775 
ºC for 15 min.
Both materials were crushed and the resulting powder 
was placed in direct contact with a specially designed ISFET 
electrode and the set immersed in SBF and the interfacial 
pH monitored. The detailed experimental set is described 
elsewhere (35, 43). The interfacial pH at the samples of 
Bioeutectics and eutectic glass grew rapidly from the initial 
value of 7.25 to 8.6-8.7 in the first 10 min of soaking, whereas 
in the bulk of the SBF solution pH remained practically 
unchanged.
In other experiment they prepared thin plates of both 
materials and immersed them in SBF for several periods of 
time. After 1 week both materials had reacted in different 
ways (Fig. 8). Bioeutectic® reacted as described above. A 
porous apatite structure resulted of the dissolution of psW 
phase and the pseudomorphic reaction of the remaining 
α-TCP into apatite as shows the micrograph of a cross section 
displayed in Fig. 8a.
On the other hand, the eutectic glass reacted forming a 
thin and dense surface layer of Ap on an intermediate layer 
of amorphous silica. They suggested that the eutectic glass 
reacted through a different mechanism, schematized in Fig. 
9. First the eutectic glass exchanges Ca2+ ions for H
3
O+ from 
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SBF which causes an increase of pH at the interface and the 
formation of a layer of amorphous silica containing silanol end 
groups. Under the alkaline conditions existing at the interface, 
part of the amorphous silica dissolves and apatite nucleates 
on the remaining amorphous matrix. The nuclei grow to 
confluence at expenses of the Ca2+, HPO
4
2-, and OH- ions in 
SBF. As the Ap layer becomes thicker the reaction slows down 
until it stops, the bulk of the glass remaining unchanged.
With this work De Aza et al. pointed out that the mechanism 
of Ap-like phase formation depends on the microstucture 
in the case of bioactive ceramic materials with identical 
chemical composition and even more, how this could affect 
the osseointegration of the ceramic implant.
Other typical case of how microstructure determines 
bioactivity was found in the system CaSiO
3
-ZrO
2
, which 
was studied by De Aza et al. who found that it is a pseudo-
binary system with a peritectic invariant point at 1467 ºC ± 
2ºC (44). They chose the composition which totally melts at 
a minimum temperature, corresponding to 13 wt.-% ZrO
2
 
(35). Then, glass-ceramics with the same composition but 
differing in microstructure were prepared from the glass with 
that composition. The glass was prepared by quenching the 
melt to room temperature and annealing at 700 ºC to remove 
stresses (35, 45, 46). Then two different processing routes 
were employed, the first consisting in bulk devitrification of 
the glass by thermal treatment in two steps (nucleation: 850 
ºC/6h; growth: 950 ºC/2h). The resulting material, called 
WZ1, presented the phase composition of Table 1, and the 
microstructure displayed in Fig. 10. To prepare the second 
material (WZ2), the glass was milled to an average particle 
size of 5 µm, the powder was isostatically pressed at 200 MPa, 
and submitted to the same thermal treatment than WZ1. 
Fig. 10a shows a SEM micrograph of a polished section of 
WZ1 glass-ceramic. W-2M nucleates as radial fibres from the 
periphery of the sample, whereas zirconia does with the shape 
of arborescent dendrites in the bulk of the sample as is shown 
in the micrograph of Fig. 10b. The gray phase surrounding 
zirconia in Fig.10 is non-devitrified amorphous glassy phase. 
In contrast the microstructure of the WZ2 glass-ceramic is 
homogeneous as displayed in Fig. 11. White areas in Fig. 11 are 
constituted of zirconia and the light grey ones to W-2M. The 
small dark grey zones correspond to residual glassy phase.
The interfacial pH of both materials was measured as 
described above and the results are shown in Fig. 12. pH 
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Fig. 9. Scheme representing the mechanism of reaction in SBF of the eutectic glass (Redrawn from (45).
increased rapidly at the SBF-WZ2 interface during the first 
minutes of soaking in SBF and remained practically constant at 
the interface SBF-WZ2. Micrographs of cross sections of plates 
of both after immersion in SBF for 1 month are displayed in 
Fig. 13. No visible reaction was observed for sample WZ1 in 
agreement with the results for the interfacial pH. On the other 
hand, WZ2 do react with SBF as other bioactive materials and 
an Ap layer is formed on its surface.
De Aza et al. explained the absence of bioactivity in WZ1 
glass-ceramic as a consequence of the low interfacial pH 
which in turn is caused by the Zr-rich residual glassy phase, 
more abundant than in WZ2. The residual glassy phase in 
contact with SBF releases Zr that precipitates at physiological 
pH on the surface of the material as oxide, hydroxide and/
or carbonate forming very thin multilayers that hinder the 
ionic exchange of H
3
O+, the first step in the typical bioactive 
reaction (35, 45, 46). Thus, they showed that materials with the 
same global chemical composition and containing the same 
crystalline phases can react differently in dependance of their 
microstructure and present distinct in vitro bioactivity.
5. the PoLymorPhIc trAnSformAtIon of trI-
cALcIum PhoSPhAte
A review of the synthesis of pure α-TCP in the literature 
reveals several contradictory results. Most of reports fail in 
obtaining pure phase instead a mixture of α- and β-phases 
is obtained. The presence of β-TCP has sometimes been 
attributed to partial reversion of the high temperature α- 
phase already formed during cooling. That is why many 
authors recommend quenching to avoid the polymorphic 
transformation α→β (47, 48).
S. De Aza was convinced that the reverse α→β 
transformation was impossible unless unusually slow cooling 
rate is employed or too large volume of reaction mass is 
involved which makes heat conduction and removal difficult 
(48). He supported this view on the fact that the polymorphic 
transformation α→β is reconstructive, according to the 
Buerger classification, i.e. ‘‘involves a major reorganization of 
the crystal structure, in which many bonds have to be broken 
and new bonds formed’’, so considerable energy has to be 
provided to the system to transform from one polymorph to 
another (49, 50). Thus, reverting from α- to β-phase should be 
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Table 1. Phase comPosiTion of The glass-ceramics deTermined by X-ray QuanTiTaTive analysis wiTh The rieTveld meThod (46).
Glass-ceramic wollastonite-2m tetragonal Zirconia Amorphous phase
WZ1 65.6 ± 1.5 6.5 ±0.6 27.9 ± 0.3
WZ2 83.5 ± 1.8 12.4 ± 0.5 4.1 ± 0.1
Fig. 10. (a) SEM micrograph of a polished section of WZ1 glass-ce-
ramic. (b) A detail of a zone of devitrification of zirconia. (Reproduced 
from 45).
Fig. 11. SEM micrograph of a polished section of WZ2 glass-ceramic. 
(Reproduced from 45).
Fig. 12. Variation of the interfacial pH for WZ1 and WZ2 glass-ceram-
ics in comparison to pH at the bulk of solution during soaking in SBF. 
(Reproduced from 45).
Fig. 13. SEM micrographs of cross sections of WZ1 and WZ2 glass-
ceramics after immersion in SBF for 1 month. (a) WZ1; (b) WZ2. 
(Reproduced from 45).
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unfeasible, unless either a very slow cooling rate or a large 
dwell at temperature slightly below that of transformation is 
used.
He believed that contradictory reports in literature were due 
to the influence of small amounts of impurities, such as Mg, 
commonly present in the materials used in the preparation of 
TCP and frequently disregarded by the investigators (47, 48).
On the other hand, S. De Aza realized that something 
had been missed out in previous studies of the system 
Ca
3
(PO
4
)
2
-Mg
3
(PO
4
)
2
 (51, 52). In these reports the boundary 
between the field of the low temperature β-TCPss and the 
high temperature α-TCPss is a line (one-dimension), which 
contradicts Palatnik–Landau’s Contact Rule of Phase Regions 
(CRPR), lately reformulated as the Boundary Theory (BT) (53-
57). As stated by the CRPR and the BT a phase boundary line 
(one-dimension) cannot separate two mono-phase fields in a 
binary phase equilibrium diagram at constant pressure (47).
Then De Aza et al. carried out several experiments to prove 
the above hypothesis. The α↔β polymorphic transformation 
was studied in real time by neutron diffraction, X-ray 
diffraction and SEM microscopy on samples of Mg-free and 
Mg-doped TCP. Their results demonstrated the existence of 
a two new biphasic fields: β+α-TCPss and α+α’-TCPss, and 
confirmed the validity of the Palatnik–Landau’s CRPR. The 
micrograph of Fig. 14 corresponds to a polished surface of 
Mg-doped TCP treated at 1300 ºC for 2 h and acid etched. Due 
to the differences in solubility of β-TCPss and α-TCPss the 
coexistence of both phases in equilibrium becomes evident. 
Besides, neutron and X-ray diffraction experiments confirmed 
the reconstructive character of the α↔β transition, which 
requires to surpass a large activation energy barrier to proceed 
and indicates that quenching is not required to retain the pure 
α-TCP phase, but it is only needed to reach a temperature 
inside the primary field of α-TCP
ss
 and to keep it for a period 
of time enough to complete the β→α transformation (47).
The results listed above permitted to redraw the phase 
equilibrium diagram of the system Mg
3
(PO
4
)
2
–Ca
3
(PO
4
)
2
 as 
shown in Fig. 15.
6. concLudInG remArkS
The four examples exposed above pretend to illustrate the 
way Salvador De Aza used to face scientific challenges. His 
method was based in a solid knowledge of Physical Chemistry, 
especially Thermodynamics and Phase Equilibrium, and 
Materials Science jointly with a careful design of experiments. 
The cases discussed constitute important contributions of 
S. De Aza to Materials Science, specifically to the field of 
Bioceramic materials.
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